Assistant Professor of Medicine, Massachusetts General Hospital
Oncology
Dr. Panagiotis M. Fidias, MD
|
|
Give Review
Panagiotis Fidias practices Oncology. Doctor Panagiotis M. Fidias, MD has written publications. He has 17 publications published with PubMed. The lastest publication is: 'Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.' Panagiotis Fidias accepts Medicare.
Publications
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
- Occult primary.
- Intracaval extension of germ cell carcinoma: diagnosis via endovascular biopsy and a review of the literature.
- Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.
- Long-term results of combined modality therapy in primary bone lymphomas.
- Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.
- Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.
- Non-Hodgkin's lymphoma presenting with biliary tract obstruction. A discussion of seven patients and a review of the literature.
- Primary tracheal non-Hodgkin's lymphoma. A case report and review of the literature.
- A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma.
- Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.
- Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.
- A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.
- Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
- Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors.
- Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 3...
Schools
University of Athens College of Medicine School of Health Science National amp Kapodistrian
University At Buffalo State University Of New York
Mass Gen Hospital
Procedures Preformed
- Thoracentesis
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of Athens
Hospital
-
St. Joseph's Hospital and Medical Center -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1396735585 | |
| NPPES Provider LastName | FIDIAS | |
| NPPES Provider FirstName | PANAGIOTIS | |
| NPPES Provider ZIPCode | 850134224 | |
| NPPES Provider State | AZ | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 565.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 47.0 | |
| Percent Opioid Claims | 8.32 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396735585 |
| Last Name Of The Provider | FIDIAS |
| First Name Of The Provider | PANAGIOTIS |
| View All |
Similar Doctors
|
Dr. Saima Saeed, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sucai Bi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Mathern, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence A. Chua, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Albert G. Wendt, MD
This Doctor is OpenDoctor Recommended.
|